Dr. Ashkin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5401 S Congress Ave
Suite 204
Atlantis, FL 33462Phone+1 561-967-4118Fax+1 561-540-3788
Education & Training
- University of Miami/Jackson Health SystemFellowship, Pulmonary Disease and Critical Care Medicine, 1990 - 1993
- Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 1986 - 1990
- New York Medical CollegeClass of 1986
Certifications & Licensure
- NY State Medical License 1988 - Present
- FL State Medical License 1990 - 2025
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 58 citationsUse of rifabutin with protease inhibitors for human immunodeficiency virus-infected patients with tuberculosis.Masahiro Narita, Jerry Jean Stambaugh, Elena S. Hollender, Denis Jones, Arthur E. Pitchenik
Clinical Infectious Diseases. 2000-05-01 - 73 citationsPharmacokinetic evaluation of rifabutin in combination with lopinavir-ritonavir in patients with HIV infection and active tuberculosis.Catherine Boulanger, Elena S. Hollender, Karen Farrell, Jerry Jean Stambaugh, Diane Maasen
Clinical Infectious Diseases. 2009-11-15 - 197 citationsAntituberculosis drug-induced hepatotoxicity. The role of hepatitis C virus and the human immunodeficiency virusJaime Ungo, Denis Jones, David Ashkin, Elena S. Hollender, David I. Bernstein
American Journal of Respiratory and Critical Care Medicine. 1998-06-01
Press Mentions
- M.D./M.P.H. Student Advances Tuberculosis Care with Groundbreaking Research on TelehealthSeptember 17th, 2024
- New Tuberculosis Drug Regimen Slashes Treatment TimeFebruary 3rd, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: